The trial produced positive results
According to federal officials with knowledge of the plan, the U.S. Food and Drug Administration (FDA) is preparing to authorize the use of the Pfizer-BioNTech vaccine against Covid-19 in teenagers aged 12 to 15 early next week. The country’s vaccination campaign has reached millions of Americans.
This news is long-awaited: since Pfizer announced the results of its clinical trials in adolescents, anxious parents have been in for several weeks, indicating that the vaccine is at least as effective in this age group as it is in adolescents.
Vaccinated children are also critical to gaining cattle immunity among the population and reducing hospitalizations and deaths.
According to federal officials, the authorization may take place as early as this weekend, and they speak anonymously because they have no right to do so.
If approved, an advisory group from the Centers for Disease Control and Prevention may meet the next day to review information from clinical trials and recommend that they use the vaccine in adolescents.
This authorization may be a major event in the US vaccination campaign, and it will be good news for parents who are eager to protect their children during summer activities and before the beginning of the next school year.